Parkinson's - McKnight's Senior Living


Pfizer to end Alzheimer’s, Parkinson’s research

Pharmaceutical company Pfizer has announced that it will end its research and development programs for Alzheimer’s and Parkinson’s treatments and “re-allocate funding to those areas where we have strong scientific leadership and that will allow us to provide the greatest impact for patients.”

Next post in News